Key Predictors for Reducing Chemotherapy-Induced Nausea and Vomiting Among Cancer Patients
Abstract
Background: Chemotherapy-induced nausea and vomiting (CINV) is a common and distressing side effect for many cancer patients. Given its high prevalence, it is essential to investigate additional factors associated with CINV. This study aimed to identify key predictors for reducing CINV in cancer patients undergoing chemotherapy.
Method: This study used a descriptive-analytical design with a cross-sectional approach conducted in one of the public hospitals in Yogyakarta from March to September 2023. Of the 100 samples purposively selected, they joined the study. Inclusion criteria were patients with any cancer type undergoing chemotherapy, aged 18 years or older, and who had signed informed consent. Exclusion criteria included patients experiencing sudden emergencies or families not consenting to data collection. Demographic characteristics and CINV moments were measured during chemotherapy sessions using the Index of Nausea, Vomiting, and Retching (INVR), which measures experiencing symptoms over the previous 12 hours. The collected data were then analyzed using descriptive statistics. The correlation between demographic characteristics and CINV was analyzed using bivariate and multivariate analyses to identify the predictors of CINV.
Results: The average INVR score among patients experiencing CINV was 9.20 ± 7.29, with a range of 0–32, and most patients experienced moderate CINV. Bivariate analysis revealed that cancer stage and the type of family caregiver were significantly correlated with CINV (both with p < 0.001). Multivariate analysis confirmed that cancer stage (β = 0.440; p < 0.001) and family caregiver type (β = 0.255; p = 0.004) were strong predictors of CINV. Patients in advanced cancer stages and those cared for by child caregivers were at higher risk for more severe CINV symptoms.
Conclusion: The findings highlight key factors associated with CINV among cancer patients. Understanding these predictors can help in developing targeted interventions to manage CINV better. Educating patients and their families about CINV management and incorporating patient feedback into care practices could improve patient outcomes and overall well-being.
Keywords
DOI: 10.33371/ijoc.v19i2.1289
Article Metrics
Abstract View: 622, 
PDF Download: 190
References
National Cancer Institute. What is cancer? [Internet]. 2021 [cited 2023 Mar 24]. Available from: https://www.cancer.gov/about-cancer/understanding/what-is-cancer
World Health Organization. Noncommunicable disease [Internet]. 2023 [cited 2024 Mar 3]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017. JAMA Oncol [Internet]. 2019 Dec 1;5(12):1749. Available from: https://jamanetwork.com/journals/jamaoncology/fullarticle/2752381
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin [Internet]. 2021 May 4;71(3):209–49. Available from: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21660
Cao W, Qin K, Li F, Chen W. Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN). J Natl Cancer Cent [Internet]. 2024 Jun;4(2):128–34. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2667005424000279
Ministry of Health of Republic Indonesia. Survei Kesehatan Indonesia 2023 [Indonesian Health Survey 2023]. Vol. 01, Jakarta. 2023.
Kim M, Park SC, Lee DY. Glycyrrhizin as a Nitric Oxide Regulator in Cancer Chemotherapy. Cancers (Basel). 2021 Nov 17;13(22):5762.
Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, et al. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis [Internet]. 2023 Jul;10(4):1367–401. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2352304222000472
Grusdat NP, Stäuber A, Tolkmitt M, Schnabel J, Schubotz B, Wright PR, et al. Routine cancer treatments and their impact on physical function, symptoms of cancer-related fatigue, anxiety, and depression. Support Care Cancer. 2022 May;30(5):3733–44.
Katta B, Vijayakumar C, Dutta S, Dubashi B, Nelamangala Ramakrishnaiah VP. The Incidence and Severity of Patient-Reported Side Effects of Chemotherapy in Routine Clinical Care: A Prospective Observational Study. Cureus [Internet]. 2023 Apr 29; Available from: https://www.cureus.com/articles/142344-the-incidence-and-severity-of-patient-reported-side-effects-of-chemotherapy-in-routine-clinical-care-a-prospective-observational-study
Papadopoulou A, Govina O, Tsatsou I, Mantzorou M, Mantoudi A, Tsiou C, et al. Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy. Med Pharm Reports. 2022 Oct 18;95(4):418–29.
Gupta K, Walton R, Kataria SP. Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends. Cancer Treat Res Commun [Internet]. 2021;26:100278. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2468294220301131
Do J, Cho Y, Jeon J. Effects of a 4-Week Multimodal Rehabilitation Program on Quality of Life, Cardiopulmonary Function, and Fatigue in Breast Cancer Patients. J Breast Cancer [Internet]. 2015;18(1):87. Available from: https://ejbc.kr/DOIx.php?id=10.4048/jbc.2015.18.1.87
Rukmi DK, Nofiyanto M. Chemotherapy-Induced Nausea and Vomiting (CINV) Based on Blood Types among Cancer Patients in Yogyakarta, Indonesia. Nurse Media J Nurs [Internet]. 2023 Aug 31;13(2):176–87. Available from: https://ejournal.undip.ac.id/index.php/medianers/article/view/48272
Escobar Y, Cajaraville G, Virizuela JA, Álvarez R, Muñoz A, Olariaga O, et al. Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study. Support Care Cancer [Internet]. 2015 Sep 17;23(9):2833–40. Available from: http://link.springer.com/10.1007/s00520-015-2809-3
Liau CT, Chu NM, Liu HE, Deuson R, Lien J, Chen JS. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians’ and nurses’ estimation vs. patients’ reported outcomes. Support Care Cancer. 2005 May 16;13(5):277–86.
Aapro M. CINV: still troubling patients after all these years. Support Care Cancer [Internet]. 2018 Mar 19;26(S1):5–9. Available from: http://link.springer.com/10.1007/s00520-018-4131-3
Brunner, Suddharth. Keperawatan Medikal Bedah. Jakarta: EGC; 2015.
Rao K V, Faso A. Chemotherapy-induced nausea and vomiting: optimizing prevention and management. Am Heal drug benefits [Internet]. 2012 Jul;5(4):232–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24991322
Sekine I, Segawa Y, Kubota K, Saeki T. Risk factors of chemotherapy-induced nausea and vomiting: Index for personalized antiemetic prophylaxis. Cancer Sci. 2013 Jun;104(6):711–7.
Rhodes VA, McDaniel RW. Nausea, Vomiting, and Retching: Complex Problems in Palliative Care. CA Cancer J Clin. 2001 Jul 1;51(4):232–48.
Prapti NKG, Petpichetchian W, Chongchareon W. Vomiting and Retching of Patients with Cervical Cancer Undergoing Chemotherapy in Bali Indonesia. Vol. 2, Chemotherapy Nurse Media Journal of Nursing. 2012.
Juartika W, Harmi PK, Fatmadona R. Gambaran Skor INVR (Index of Nausea, Vomiting and Retching) pada CINV (Chemotherapy Induced Nausea and Vomiting) Kanker Payudara di RSUP M Djamil Padang. J Kesehat Andalas. 2020 Jan 13;8(4).
Navari RM. Nausea and Vomiting in Advanced Cancer. Curr Treat Options Oncol. 2020 Feb 5;21(2):14.
Li K, Cai Y, Xie S, Zhou Y, Dong J, Zhu Q, et al. Evidence Summary for Nonpharmacological Management of Chemotherapy-Induced Nausea and Vomiting. Biomed Res Int. 2022 Nov 23;2022:1–10.
Mosa ASM, Hossain AM, Lavoie BJ, Yoo I. Patient-Related Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review. Front Pharmacol. 2020 Apr 1;11.
Kawazoe H, Murakami A, Yamashita M, Nishiyama K, Kobayashi-Taguchi K, Komatsu S, et al. Patient-related Risk Factors for Nausea and Vomiting with Standard Antiemetics in Patients with Breast Cancer Receiving Anthracycline-based Chemotherapy: A Retrospective Observational Study. Clin Ther. 2018;40(12):2170–9.
Roeland EJ, Ruddy KJ, LeBlanc TW, Nipp RD, Binder G, Sebastiani S, et al. What the HEC? Clinician Adherence to Evidence-Based Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy. J Natl Compr Cancer Netw [Internet]. 2020 Jun;18(6):676–81. Available from: https://jnccn.org/view/journals/jnccn/18/6/article-p676.xml
Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, et al. Antiemetics: ASCO Guideline Update. J Clin Oncol [Internet]. 2020 Aug 20;38(24):2782–97. Available from: https://ascopubs.org/doi/10.1200/JCO.20.01296
Chen W, Zhao Y, Dai Y, Nie K. Gastrointestinal inflammation plays a critical role in chemotherapy-induced nausea and vomiting. Eur J Pharmacol [Internet]. 2022 Dec;936:175379. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0014299922006409
Oh EG. Symptom experience in Korean adults with lung cancer. J Pain Symptom Manage. 2004 Aug;28(2):133–9.
Ng B, Astari YK, Adrian Wiranata J, Leo B, Hutajulu SH, Hardianti MS, et al. Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer: Risk Factor and Predictive Model Using Classification and Regression Tree (CART). Cureus. 2023 Aug 31;
Huang XJ, Li XY, Li JH, Hu ZY, Luo L, Tan Y, et al. Nomogram for Predicting Chemotherapy-Induced Nausea and Vomiting for Breast Cancer Patients. Tohoku J Exp Med. 2021;254(2):111–21.
Syse A, Lyngstad TH. In sickness and in health: The role of marital partners in cancer survival. SSM - Popul Heal. 2017 Dec;3:99–110.
Pethybridge R, Teleni L, Chan RJ. How do family-caregivers of patients with advanced cancer provide symptom self-management support? A qualitative study. Eur J Oncol Nurs. 2020 Oct;48:101795.
Gour S, Kore A, Das A, Dane J, Maurya RK. A Qualitative Study to Explore Patient’s experiences on Chemotherapy-induced Nausea and Vomiting: Focusing Impact on Daily Life. Asian Pacific J Cancer Care. 2022;8(1):21–8.
Valente M, Chirico I, Ottoboni G, Chattat R. Relationship Dynamics among Couples Dealing with Breast Cancer: A Systematic Review. Int J Environ Res Public Health. 2021 Jul 7;18(14):7288.
Lavdaniti M, Tsitsis N. Investigation of nausea and vomiting in cancer patients undergoing chemotherapy. Heal Psychol Res [Internet]. 2014 Oct 22;2(3). Available from: https://healthpsychologyresearch.openmedicalpublishing.org/article/22407
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Email this article 
